A new guidance document released by the U.S. Food and Drug Administration finally addresses the topic of clinical research as it relates to cannabis and derivative products.
Anticipated FDA guidelines fall short of cannabis sector’s expectations is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
Read More: Anticipated FDA guidelines fall short of cannabis sector’s expectations
Comments are closed, but trackbacks and pingbacks are open.